These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 28478491)

  • 1. Letter to the editor.
    Lyske J; Sathyanarayana R
    Abdom Radiol (NY); 2017 Nov; 42(11):2781-2782. PubMed ID: 28478491
    [No Abstract]   [Full Text] [Related]  

  • 2. [5. Inspection of Hepatocellular Carcinoma 3-Contrast for the Diagnosis of Hepatocellular Carcinoma: Techniques of Image Contrast and the Choice of MR Contrast Agent].
    Kitoh Y
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2016 May; 72(5):441-51. PubMed ID: 27211090
    [No Abstract]   [Full Text] [Related]  

  • 3. Personalized management of patients with very early hypovascular hepatocellular carcinoma.
    Cucchetti A; Vitale A
    Liver Int; 2018 Mar; 38(3):415-416. PubMed ID: 29469211
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatocellular carcinoma: optimal staging impacts survival.
    Reeves HL; Aisen AM
    Gastroenterology; 2015 Jun; 148(7):1274-6. PubMed ID: 25921373
    [No Abstract]   [Full Text] [Related]  

  • 5. Paradoxical high signal intensity of hepatocellular carcinoma in the hepatobiliary phase of Gd-EOB-DTPA enhanced MRI: initial experience.
    Lee SA; Lee CH; Jung WY; Lee J; Choi JW; Kim KA; Park CM
    Magn Reson Imaging; 2011 Jan; 29(1):83-90. PubMed ID: 20832227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receiver operating characteristic curve analysis, sensitivity comparison and individual difference.
    Kawada T
    Clin Radiol; 2012 Sep; 67(9):940. PubMed ID: 22608247
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of hepatocellular carcinoma with dynamic MR imaging during intraarterial infusion of gadopentetate dimeglumine.
    Fujita T; Ito K; Choji T; Honjo K; Matsumoto T; Arita T; Nakanishi T
    AJR Am J Roentgenol; 1994 Oct; 163(4):865-6. PubMed ID: 8092025
    [No Abstract]   [Full Text] [Related]  

  • 8. [Magnetic resonance tomography of focal hepatic lesions using the para-magnetic contrast medium, gadolinium DTPA. First clinical results].
    Hamm B; Römer T; Felix R; Wolf KJ
    Rofo; 1986 Dec; 145(6):684-91. PubMed ID: 3025957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal scanning protocol of arterial dominant phase for hypervascular hepatocellular carcinoma with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MR.
    Kagawa Y; Okada M; Kumano S; Katsube T; Imaoka I; Tanigawa N; Ishii K; Kudo M; Murakami T
    J Magn Reson Imaging; 2011 Apr; 33(4):864-72. PubMed ID: 21448951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Will CT take second billing to MR imaging for the diagnosis of hypervascular hepatocellular carcinomas hereafter?
    Kanematsu M
    Radiology; 2011 Aug; 260(2):607; author reply 607-8. PubMed ID: 21778455
    [No Abstract]   [Full Text] [Related]  

  • 11. Education and imaging. Hepatobiliary and Pancreatic: Detection of early hepatocellular carcinoma by enhanced magnetic resonance imaging.
    Eso Y; Marusawa H; Osaki Y
    J Gastroenterol Hepatol; 2012 Feb; 27(2):416. PubMed ID: 22260287
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dynamic MRI].
    Araki T; Ichikawa T; Nakajima H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():292-5. PubMed ID: 11761959
    [No Abstract]   [Full Text] [Related]  

  • 13. [Differentiation of focal liver lesions using contrast-enhanced MRT].
    Heintz P; Ehrenheim C
    Rofo; 1989 Mar; 150(3):297-306. PubMed ID: 2538880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conclusive HCC diagnosis with hepatocyte-specific contrast-enhanced magnetic resonance imaging? Not yet.
    Forner A; Rimola J; Ayuso C
    J Hepatol; 2016 Sep; 65(3):648-9. PubMed ID: 27312943
    [No Abstract]   [Full Text] [Related]  

  • 15. MR-guided ablation of hepatocellular carcinoma aided by gadoxetic acid.
    Bathe OF; Mahallati H
    J Surg Oncol; 2007 Jun; 95(8):670-3. PubMed ID: 17345591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reply to: "Conclusive HCC diagnosis with hepatocyte-specific contrast-enhanced magnetic resonance imaging? Not yet".
    Choi SH; Byun JH
    J Hepatol; 2016 Sep; 65(3):650-1. PubMed ID: 27349489
    [No Abstract]   [Full Text] [Related]  

  • 17. Signal Intensity Increase in the Central Nervous System after Previous Gadoxetic Acid-enhanced MR Imaging.
    Harz C; Schöckel L; Endrikat J; Pietsch H; Balzer T
    Radiology; 2017 Jul; 284(1):299-301. PubMed ID: 28628415
    [No Abstract]   [Full Text] [Related]  

  • 18. Letter to the Editor on "LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations". Ultraschall in Med 2016; 37: 627-634.
    Strobel D; Schellhaas B
    Ultraschall Med; 2017 Jan; 38(1):87. PubMed ID: 28249329
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.
    Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK
    J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Education and Imaging. Hepatobiliary and pancreatic: malignant wash-out pattern of hepatocellular cancer using dynamic MR imaging.
    Cubuk R; Tasali N
    J Gastroenterol Hepatol; 2009 Jun; 24(6):1151. PubMed ID: 19638095
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.